Local Response
tumor, sarcoma
TUMOR, SARCOMA
All patients achieved local control of the injected target lesions after 8 doses. One patient (8%) had complete response in the injected tumor, whereas 4 other patients (33%) had durable local response with greater than 25% size reduction. In this small cohort, there was no apparent association between local response and dosage, sarcoma subtype, previous therapies, number of metastatic sites, age, or sex (eTable and eFigure 4 in 